Trial Profile
Phase Ⅲ Clinical Study of Recombinant Human Growth Hormone Injection (JINTOPIN AQ) for Short Children With Small for Gestational Age(SGA)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Oct 2023
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Short stature
- Focus Registrational; Therapeutic Use
- Sponsors GeneScience Pharmaceuticals
- 16 Aug 2017 New trial record